Urinary-cell mRNA and acute kidney-transplant rejection.

Advances in diagnostics for transplant rejection. Expert Rev Mol Diagn (2016) 0.75

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.89

Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.89

Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.88

Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.88

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer. Clin Cancer Res (2004) 5.40

Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med (2005) 5.02

Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest (2010) 3.59

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med (2007) 2.86

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation (2002) 2.86

MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A (2009) 2.36

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2007) 2.10

Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int (2003) 1.83

Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation (2014) 1.60

Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation (2008) 1.50

Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int (2004) 1.48

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation (2002) 1.33

Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression. Transplantation (2003) 1.16

MicroRNAs: small RNAs with big effects. Transplantation (2010) 1.15

Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy. Hypertension (2012) 1.14

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation (2005) 1.13

Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Med (2014) 1.10

Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts. Transplantation (2007) 1.08

CD103 mRNA levels in urinary cells predict acute rejection of renal allografts. Transplantation (2003) 1.07

Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection. Transplantation (2004) 1.07

Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol (2006) 1.05

Transforming growth factor beta and progression of renal disease. Kidney Int Suppl (2003) 1.04

MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation (2012) 1.03

Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med (2006) 1.01

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99

Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant (2010) 0.98

Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation (2012) 0.98

Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation (2003) 0.96

Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation (2008) 0.95

Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets. Transplantation (2005) 0.94

Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94

Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2. Transplantation (2002) 0.90

Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts. Transplantation (2010) 0.90

Enforced c-REL deficiency prolongs survival of islet allografts1. Transplantation (2002) 0.89

Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation (2013) 0.88

Urinary cell mRNA profiles predictive of human kidney allograft status. Immunol Rev (2014) 0.88

Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. Transpl Immunol (2004) 0.87

Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients. Transplantation (2014) 0.87

Transcriptional profiling to assess the clinical status of kidney transplants. Nat Clin Pract Nephrol (2006) 0.85

Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys. Transplantation (2012) 0.85

On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. Transplantation (2013) 0.85

Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation (2003) 0.85

Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83

Vesicoureteric reflux and reflux nephropathy as seen at a tertiary care adult nephrology service in India--an analysis of 86 patients. Ren Fail (2003) 0.82

Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc (2009) 0.82

Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function. Transplantation (2010) 0.82

Noninvasive diagnosis of acute rejection of solid organ transplants. Front Biosci (2004) 0.81

Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Transplantation (2012) 0.81

Noninvasive prognostication of polyomavirus BK virus-associated nephropathy. Transplantation (2013) 0.80

The natural history, risk factors and outcomes of polyomavirus BK-associated nephropathy after renal transplantation. Nat Clin Pract Nephrol (2006) 0.78

Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Transplantation (2012) 0.78

HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. Clin Transpl (2013) 0.78

Treating IgA nephropathy: quid novi? Discov Med (2014) 0.77

Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure. Transplantation (2015) 0.77

Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy. Kidney Int (2016) 0.76

HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles. Transplantation (2013) 0.76

Transplantation: Pump it up: conserving a precious resource? Nat Rev Nephrol (2009) 0.75

Should hepatitis C virus infection be a contraindication to renal transplantation? Nat Clin Pract Nephrol (2008) 0.75

Excretion of anti-angiogenic proteins in patients with chronic allograft dysfunction. Nephrol Dial Transplant (2012) 0.75

Transplantation: Personalizing induction therapy in kidney transplantation. Nat Rev Nephrol (2009) 0.75

Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. Transplantation (2003) 0.75

Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy. J Nephrol (2014) 0.75

Excellent outcomes with expanded criteria donor kidneys: the role of the recipient's age. Clin Transpl (2013) 0.75

Transplantation: a report of progress. Transplantation (2008) 0.75

Optimal modes and targets of gene therapy in transplantation. Immunol Rev (2003) 0.75

Urine injury biomarkers are not associated with kidney transplant failure. Transplantation (2019) 0.75

Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction. Transplantation (2012) 0.75

Transplantation: a report of progress. Transplantation (2010) 0.75

Transplantation: a report of progress. Transplantation (2013) 0.75

The Nobel Prize-winning work of Ralph Steinman (1943-2011) and its relevance to transplantation. Transplantation (2013) 0.75